Phase 3 Isradipine Results Coming Soon - Cure Parkinson's

Cure Parkinson's

25,463 members26,773 posts

Phase 3 Isradipine Results Coming Soon

jimcaster profile image
12 Replies

The last person being studied in Phase 3 Israpidine study will be done this November. Results will be out 3 to 6 months later and it may be the first readily available drug shown to delay progression in PD.

parkinsonsdisease.net/resea...

Written by
jimcaster profile image
jimcaster
To view profiles and participate in discussions please or .
Read more about...
12 Replies
jimcaster profile image
jimcaster

More israpidine info: michaeljfox.org/foundation/...

stepan13 profile image
stepan13

I am taking isradipine 5mg 2times a day for the last 5 years since I had been diagnosed. Still alive. Still have PD.

jimcaster profile image
jimcaster in reply to stepan13

Since you have been taking it for five years, have you noticed a benefit -- such as slower disease progression than peer, etc.? Obviously, there's no way to know if your condition would be worse if you were not taking it, but I assume you must believe there is some benefit. I sure hope so. 😊

WinnieThePoo profile image
WinnieThePoo

I think there are signs this may be the first real disease modifier to make it to licencing. I hope that doesn't jinx it with "commentators curse". Since I have BP that is at best 140/90 and a French GP, who knows I want Isradipine for PD, prepared to prescribe it with a straight face for my hypertension, I have been exhibiting admirable restraint and calm in not popping this pill.

First, there has been a lot of press for lab tests with mice earlier this year suggesting an explanation of the method by which this drug slows PD. Second, this is a full blown large scale 3 year trial, and it has made it to the finish line. If results were evidently poor I suspect it would have blown up and finished early.

Exanatide is the other very promising drug, so its frustrating that its phase 3 has yet to get off the ground.

bassofspades profile image
bassofspades

My 2 cents. I took isradipine for a year. No loss and no gain from it. But thiamine halts progression, resolves symptoms and is safe, so why not just use that? Isradipine is a blood pressure medication so risk of side effects is higher than b1.

jimcaster profile image
jimcaster in reply to bassofspades

Bass, when you say "no loss and no gain" do you mean your symptoms stayed the same for a year? If so, that sounds great. I sure hope you are right regarding thiamine. I am now at the six month mark with thiamine and truly feel better than when I was diagnosed, but the lawyer in me keeps anticipating and/or preparing for the worst case scenario. Even though I keep telling myself to live for today, I keep worrying about tomorrow and wondering if this thiamine stuff is too good to be true. Although I'm growing increasingly frustrated with the established medical community, I just wish someone within the established research/medical community would validate or support Dr. Costantini's efforts...

bassofspades profile image
bassofspades in reply to jimcaster

Just to clarify, no loss no gain means i didn't get worse or better. On thiamine, however, i did get better and i trust what Dr Costantini said about never getting worse. So therefore i see no point to isradipine. Thiamine is better in every way. At least that's my 2 cents. ...unless you are already using isradipine for your blood pressure. But my dr said its not commonly used for BP anymore. Used to be called Dynacirc.

jimcaster profile image
jimcaster in reply to bassofspades

I sure hope you are right and I have nothing in my personal experience with thiamine to doubt you. When did you start on thiamine and what is your current dose? I started around May 20 and have settled in at 1.5 grams per day.

bassofspades profile image
bassofspades in reply to jimcaster

Started in feb 2018. Currently on 2.5 g per day. Started with 4, then 3, then 2.5g. It's been great for me.

bassofspades profile image
bassofspades in reply to jimcaster

Have faith, dr. Costantini knows what he is doing.

Highway17 profile image
Highway17

Not good news. Results just released at AAN Conference were negative aan.com/PressRoom/Home/Pres...

jimcaster profile image
jimcaster in reply to Highway17

I wish there was an icon other than a thumbs up. This is a thumbs down for sure. Dang.

You may also like...

Anyone participating in the Buntanetap Phase 3 trial?

here: https://clinicaltrials.gov/ct2/show/NCT05357989 Previously discussed on HU here:...

First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's

coordination....

Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered

initiated the 2nd late-stage study of their LRRK2 inhibitor BIIB122; Phase 3, randomized,...

ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE

AnnovisBio gets the nod from US_FDA for their Phase 3 clinical study of Buntanetap (Posiphen) in...

Vitamin B3 trial results

with #Parkinsons; 3-month double-blinded (vs placebo) run-in + 12 month open label study; 3.5 point...